The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Cascade Bancorp | Common Stock | 147154207 | 59,523 | 11,468,750 | SH | DFND | WL Ross | 11,468,750 | 0 | 0 | |
Exco Resources Inc. | Common Stock | 269279402 | 110,896 | 51,104,050 | SH | DFND | WL Ross | 51,104,050 | 0 | 0 | |
Navigator Holdings Ltd. | Common Stock | Y62132108 | 460,453 | 21,863,874 | SH | DFND | WL Ross | 21,863,874 | 0 | 0 | |
Sun Bancorp Inc. | Common Stock | 86663B102 | 82,563 | 4,255,848 | SH | DFND | WL Ross | 4,255,848 | 0 | 0 | |
Talmer Bancorp Inc | Common Stock | 87482X101 | 135,691 | 9,664,579 | SH | DFND | WL Ross | 9,664,579 | 0 | 0 | |
Cyclacel Pharmaceuticals | Common Stock | 23254L306 | 41 | 58,158 | SH | DFND | IPC | 58,158 | 0 | 0 | |
E2Open, Inc. | Common Stock | 29788A104 | 6,449 | 671,123 | SH | DFND | IPC | 671,123 | 0 | 0 | |
Inphi Corporation | Common Stock | 45772F107 | 1,320 | 71,424 | SH | DFND | IPC | 71,424 | 0 | 0 | |
Xenon Pharmaceutical, Inc. | Common Stock | 98420N105 | 8,782 | 444,655 | SH | DFND | IPC | 444,655 | 0 | 0 |